Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-20266 · Session 4

What guidance it has given to NHS boards on ensuring equality of access to all second line preventative medicines for people identified as …

Answered Asked by Dr Richard Simpson Lab Lodged 19 Mar 2014

The question

To ask the Scottish Government what guidance it has given to NHS boards on ensuring equality of access to all second line preventative medicines for people identified as being at risk of osteoporotic fracture.

The answer

Answered by Michael Matheson on 27 Mar 2014 · 8 days after it was lodged, on time

Patients at risk of osteoporosis should be treated according to current clinical guidelines.
The Scottish Intercollegiate Guidelines Network (SIGN) is updating its guideline on the management of Osteoporosis to incorporate the significant advances in the management of this condition, including the arrival of new treatments. The revised SIGN guideline is expected to be published this summer. Current SIGN guidelines can be found at:
http://sign.ac.uk/guidelines/fulltext/71/index.html
The National Institute for Health and Clinical Excellence published guidance (CG146) in August 2012 on assessing the risk of fragility fracture in osteoporosis:
http://pathways.nice.org.uk/pathways/osteoporosis

In the Official Report

No contribution in the Official Report cites S4W-20266 by reference.